My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (Text with EEA relevance.)

Implementing Regulation (EU) 2018/1266 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 316, Cycloxydim, the date is replaced by ‘31 May 2023’; (2) in the sixth column, expiration of approval, of row 317, 6-Benzyladenine, the date is replaced by ‘31 May 2024’; (3) in the sixth column, expiration of approval, of row 322, Hymexazol, the date is replaced by ‘31 May 2023’; (4) in the sixth column, expiration of approval, of row 323, Dodine, the date is replaced by ‘31 May 2024’; (5) in the sixth column, expiration of approval, of row 326, Indolylbutyric acid, the date is replaced by ‘31 May 2023’; (6) in the sixth column, expiration of approval, of row 328, Tau-fluvalinate, the date is replaced by ‘31 May 2024’; (7) in the sixth column, expiration of approval, of row 329, Clethodim, the date is replaced by ‘31 May 2023’; (8) in the sixth column, expiration of approval, of row 330, Bupirimate, the date is replaced by ‘31 May 2024’; (9) in the sixth column, expiration of approval, of row 333, 1-decanol, the date is replaced by ‘31 May 2024’; (10) in the sixth column, expiration of approval, of row 334, Isoxaben, the date is replaced by ‘31 May 2024’; (11) in the sixth column, expiration of approval, of row 335, Fluometuron, the date is replaced by ‘31 May 2024’; (12) in the sixth column, expiration of approval, of row 337, Carboxin, the date is replaced by ‘31 May 2023’; (13) in the sixth column, expiration of approval, of row 339, Dazomet, the date is replaced by ‘31 May 2023’; (14) in the sixth column, expiration of approval, of row 340, Metaldehyde, the date is replaced by ‘31 May 2023’; (15) in the sixth column, expiration of approval, of row 341, Sintofen, the date is replaced by ‘31 May 2024’; (16) in the sixth column, expiration of approval, of row 342, Fenazaquin, the date is replaced by ‘31 May 2023’; (17) in the sixth column, expiration of approval, of row 343, Azadirachtin, the date is replaced by ‘31 May 2024’; (18) in the sixth column, expiration of approval, of row 344, Diclofop, the date is replaced by ‘31 May 2023’; (19) in the sixth column, expiration of approval, of row 345, Lime sulphur, the date is replaced by ‘31 May 2024’; (20) in the sixth column, expiration of approval, of row 346, Aluminium sulfate, the date is replaced by ‘31 May 2024’; (21) in the sixth column, expiration of approval, of row 348, Paclobutrazol, the date is replaced by ‘31 May 2023’; (22) in the sixth column, expiration of approval, of row 349, Pencycuron, the date is replaced by ‘31 May 2024’; (23) in the sixth column, expiration of approval, of row 350, Tebufenozide, the date is replaced by ‘31 May 2024’; (24) in the sixth column, expiration of approval, of row 351, Dithianon, the date is replaced by ‘31 May 2024’; (25) in the sixth column, expiration of approval, of row 352, Hexythiazox, the date is replaced by ‘31 May 2024’; (26) in the sixth column, expiration of approval, of row 353, Flutriafol, the date is replaced by ‘31 May 2024’.

Other acts of the same type
Commission Implementing Regulation (EU) 2022/652 of 20 April 2022 concerning the authorisation of bitter orange extract as a feed additive for certain animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/653 of 20 April 2022 concerning the authorisation of a preparation of the leaves extract of Melissa officinalis L. as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/654 of 20 April 2022 concerning the authorisation of butylated hydroxyanisole as a feed additive for cats (Text with EEA relevance)Commission Delegated Regulation (EU) 2022/1302 of 20 April 2022 supplementing Directive 2014/65/EU of the European Parliament and of the Council with regard to regulatory technical standards for the application of position limits to commodity derivatives and procedures for applying for exemption from position limits (Text with EEA relevance)Council Regulation (EU) 2022/625 of 13 April 2022 amending Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Regulation (EU) 2022/626 of 13 April 2022 amending Regulation (EU) 2022/263 concerning restrictive measures in response to the recognition of the non-government controlled areas of the Donetsk and Luhansk oblasts of Ukraine and the ordering of Russian armed forces into those areasCommission Implementing Regulation (EU) 2022/632 of 13 April 2022 setting out temporary measures in respect of specified fruits originating in Argentina, Brazil, South Africa, Uruguay and Zimbabwe to prevent the introduction into, and the spread within, the Union territory of the pest Phyllosticta citricarpa (McAlpine) Van der AaCommission Implementing Regulation (EU) 2022/633 of 13 April 2022 concerning the authorisation of a preparation of Lactiplantibacillus plantarum DSM 26571 as a silage additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/634 of 13 April 2022 amending Regulation (EU) No 37/2010 as regards the classification of the substance bambermycin with respect to its maximum residue limit in foodstuffs of animal origin (Text with EEA relevance)Regulation (EU) 2022/613 of the European Parliament and of the Council of 12 April 2022 amending Regulations (EU) No 1303/2013 and (EU) No 223/2014 as regards increased pre-financing from REACT-EU resources and the establishment of a unit costCommission Implementing Regulation (EU) 2022/619 of 12 April 2022 terminating the ‘new exporter’ reviews of Implementing Regulation (EU) 2017/2230 imposing a definitive anti-dumping duty on imports of trichloroisocyanuric acid originating in the People’s Republic of China, for three Chinese exporting producers, imposing the duty with regard to these producers’ imports and terminating the registration of these importsRegulation (EU) 2022/641 of the European Parliament and of the Council of 12 April 2022 amending Regulation (EU) No 536/2014 as regards a derogation from certain obligations concerning investigational medicinal products made available in the United Kingdom in respect of Northern Ireland and in Cyprus, Ireland and Malta (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next